Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Increased frequency of systemic pro-inflammatory Vδ1 + γδ T cells in HIV elite controllers correlates with gut viral load.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- معلومة اضافية
- المصدر:
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
- بيانات النشر:
Original Publication: London : Nature Publishing Group, copyright 2011-
- الموضوع:
- نبذة مختصرة :
γδ T cells predominate in the intestinal mucosa and help maintain gut homeostasis and mucosal immunity. Although HIV infection significantly alters these cells, what drives these perturbations is unclear. Growing evidence suggests that impaired intestinal immune function in HIV leads to chronic immune activation and disease progression. This occurs even in HIV controllers - individuals with undetectable HIV viremia without antiretroviral therapy (ART). We show that Vδ1 + cells, a subset of γδ T cells described as being important in intestinal barrier function, increase in frequency in HIV-infected individuals, including HIV controllers. These cells resemble terminally differentiated effector memory cells, producing the pro-inflammatory cytokines IFNγ, TNFα, and MIP-1β upon stimulation. Importantly, pro-inflammatory Vδ1 + cell frequency correlates with levels of HIV RNA in intestinal tissue but not in plasma. This study supports a model in which local viral replication in the gut in HIV controllers disrupts the phenotype and function of Vδ1 + cells, a cell type involved in the maintenance of epithelial barrier integrity, and may thereby contribute to systemic immune activation and HIV disease progression.
- References:
Immunology. 2014 Apr;141(4):596-608. (PMID: 24266436)
PLoS One. 2014 Sep 04;9(9):e106064. (PMID: 25188438)
Nat Rev Immunol. 2003 Mar;3(3):233-42. (PMID: 12658271)
J Exp Med. 2003 Aug 4;198(3):391-7. (PMID: 12900516)
Am J Surg Pathol. 2013 Mar;37(3):375-84. (PMID: 23348211)
J Infect Dis. 2010 Nov 15;202(10):1553-61. (PMID: 20939732)
J Immunol. 1997 Oct 1;159(7):3629-37. (PMID: 9317163)
J Infect Dis. 2008 Mar 1;197(5):714-20. (PMID: 18260759)
Annu Rev Med. 2011;62:141-55. (PMID: 21090961)
Cytometry A. 2011 Feb;79(2):167-74. (PMID: 21265010)
Clin Exp Immunol. 1991 Feb;83(2):187-91. (PMID: 1825186)
Hum Immunol. 2010 Oct;71(10):968-75. (PMID: 20600446)
Immunol Rev. 2013 Sep;255(1):165-81. (PMID: 23947354)
Int Immunol. 2000 Jun;12(6):797-805. (PMID: 10837407)
Blood. 2009 Jun 25;113(26):6611-8. (PMID: 19395673)
AIDS. 2012 Nov 28;26(18):2409-12. (PMID: 23032411)
Microbes Infect. 2005 Mar;7(3):518-28. (PMID: 15777667)
PLoS One. 2015 Jun 18;10(6):e0129771. (PMID: 26086523)
PLoS One. 2012;7(9):e44454. (PMID: 22970224)
J Virol. 1996 Jun;70(6):3545-50. (PMID: 8648688)
Clin Immunol Immunopathol. 1996 May;79(2):189-93. (PMID: 8620625)
Immunology. 2012 Jul;136(3):283-90. (PMID: 22385416)
AIDS. 2013 Sep 10;27(14):2255-60. (PMID: 24157906)
Clin Exp Immunol. 1989 Feb;75(2):206-10. (PMID: 2522839)
J Infect Dis. 2008 Jan 1;197(1):126-33. (PMID: 18171295)
J Virol. 2003 Oct;77(19):10456-67. (PMID: 12970431)
Immunol Rev. 2013 Jul;254(1):78-101. (PMID: 23772616)
J Infect Dis. 2015 Apr 1;211(7):1068-75. (PMID: 25344521)
Am J Reprod Immunol. 2016 Feb;75(2):134-45. (PMID: 26666220)
J Immunol. 2015 Jun 15;194(12):5953-60. (PMID: 25964489)
Immunity. 2009 Aug 21;31(2):184-96. (PMID: 19699170)
Eur J Immunol. 1991 Apr;21(4):1053-9. (PMID: 1826884)
PLoS Pathog. 2015 Oct 16;11(10):e1005201. (PMID: 26473478)
Nat Med. 2005 Apr;11(4 Suppl):S25-32. (PMID: 15812486)
Blood. 2012 Apr 26;119(17):4013-6. (PMID: 22403253)
Immunol Cell Biol. 1995 Jun;73(3):245-8. (PMID: 7590898)
Trends Microbiol. 2013 Jan;21(1):6-13. (PMID: 23062765)
Nat Rev Immunol. 2013 Feb;13(2):88-100. (PMID: 23348415)
PLoS Pathog. 2013;9(10):e1003691. (PMID: 24130489)
Br J Haematol. 2002 Jul;118(1):282-8. (PMID: 12100163)
Curr HIV/AIDS Rep. 2007 Feb;4(1):10-5. (PMID: 17338855)
Cell Mol Immunol. 2013 Jan;10(1):30-4. (PMID: 23085943)
J Immunol Methods. 2003 Aug;279(1-2):17-31. (PMID: 12969544)
PLoS One. 2012;7(1):e29066. (PMID: 22238587)
Annu Rev Anim Biosci. 2013 Jan;1:99-124. (PMID: 25387013)
Blood. 2010 Nov 18;116(20):4148-57. (PMID: 20660793)
J Infect Dis. 2010 Dec 15;202(12):1846-54. (PMID: 21050120)
Cell Mol Immunol. 2013 Jan;10(1):42-9. (PMID: 23241900)
- Grant Information:
P30 DK043351 United States DK NIDDK NIH HHS
- الرقم المعرف:
0 (Cytokines)
0 (Inflammation Mediators)
0 (Receptors, Antigen, T-Cell, gamma-delta)
- الموضوع:
Date Created: 20181109 Date Completed: 20191028 Latest Revision: 20191107
- الموضوع:
20240829
- الرقم المعرف:
PMC6220338
- الرقم المعرف:
10.1038/s41598-018-34576-4
- الرقم المعرف:
30405182
No Comments.